Dendritic cell deficiencies in pediatric acute lymphoblastic leukemia patients

Leukemia

Volumn 20, Issue 4, 2006, Pages 645-649

  Maecker, B ^a   Mougiakakos, D ^a   Zimmermann, M ^a   Behrens, M ^a   Hollander, S ^a   Schrauder, A ^b   Schrappe, M ^b   Welte, K ^a   Klein, C ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

Acute lymphoblastic leukemia; Dendritic cell; Flow cytometry; Tumor immunology

Indexed keywords

GLYCOPROTEIN P 15095; HLA DR ANTIGEN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ANTIGEN EXPRESSION; ARTICLE; BLAST CELL; CELL COUNT; CELL DIFFERENTIATION; CELL LINEAGE; CHILD; CHILDHOOD LEUKEMIA; CONTROLLED STUDY; CORRELATION ANALYSIS; DENDRITIC CELL; DISEASE MARKER; FEMALE; FLOW CYTOMETRY; GRANULOCYTE; HUMAN; HUMAN CELL; LEUKEMIA CELL; MAJOR CLINICAL STUDY; MALE; MONOCYTE; MYELOPOIESIS; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; TUMOR IMMUNITY;

EID: 33646468528     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/sj.leu.2404146     Document Type: Article

References (23)

1. Schrappe M, Camitta B, Pui CH, Eden T, Gaynon P, Gustafsson G et al. Long-term results of large prospective trials in childhood acute lymphoblastic leukemia. Leukemia 2000; 14: 2193-2194.
2. Schrappe M, Reiter A, Ludwig WD, Harbott J, Zimmermann M, Hiddemann W et al. Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: Results of trial ALL-BFM 90. German-Austrian-Swiss ALL-BFM Study Group. Blood 2000; 95: 3310-3322.
3. LeClerc JM, Billett AL, Gelber RD, Dalton V, Tarbell N, Lipton JM et al. Treatment of childhood acute lymphoblastic leukemia: Results of Dana-Farber ALL Consortium Protocol 87-01. J Clin Oncol 2002; 20: 237-246.
4. Woolfrey AE, Anasetti C, Storer B, Doney K, Milner LA, Sievers EL et al. Factors associated with outcome after unrelated marrow transplantation for treatment of acute lymphoblastic leukemia in children. Blood 2002; 99: 2002-2008.
5. Gustafsson Jernberg A, Remberger M, Ringden O, Winiarski J. Graft-versus-leukaemia effect in children: Chronic GVHD has a significant impact on relapse and survival. Bone Marrow Transplant 2003; 31: 175-181.
6. Cardoso AA, Seamon MJ, Afonso HM, Ghia P, Boussiotis VA, Freeman GJ et al. Ex vivo generation of human anti-pre-B leukemia-specific autologous cytolytic T cells. Blood 1997; 90: 549-561.
7. Cardoso AA, Veiga JP, Ghia P, Afonso HM, Haining WN, Sallan SE et al. Adoptive T-cell therapy for B-cell acute lymphoblastic leukemia: preclinical studies. Blood 1999; 94: 3531-3540.
8. Stripecke R, Skelton DC, Gruber T, Afar D, Pattengale PK, Witte ON et al. Immune response to Philadelphia chromosome-positive acute lymphoblastic leukemia induced by expression of CD80, interleukin 2, and granulocyte-macrophage colony-stimulating factor. Hum Gene Ther 1998; 9: 2049-2062.
9. Auffermann-Gretzinger S, Keeffe EB, Levy S. Impaired dendritic cell maturation in patients with chronic, but not resolved, hepatitis C virus infection. Blood 2001; 97: 3171-3176.
10. Chehimi J, Campbell DE, Azzoni L, Bacheller D, Papasavvas E, Jerandi G et al. Persistent decreases in blood plasmacytoid dendritic cell number and function despite effective highly active antiretroviral therapy and increased blood myeloid dendritic cells in HIV-infected individuals. J Immunol 2002; 168: 4796-4801.
11. Mohty M, Jarrossay D, Lafage-Pochitaloff M, Zandotti C, Briere F, de Lamballeri XN et al. Circulating blood dendritic cells from myeloid leukemia patients display quantitative and cytogenetic abnormalities as well as functional impairment. Blood 2001; 98: 3750-3756.
12. Mohty M, Isnardon D, Vey N, Briere F, Blaise D, Olive D et al. Low blood dendritic cells in chronic myeloid leukaemia patients correlates with loss of CD34+/CD38 primitive haematopoietic progenitors. Br J Haematol 2002; 119: 115-118.
13. Bourguin-Plonquet A, Rouard H, Roudot-Thoraval F, Bellanger C, Marquet J, Delfau-Larue MH et al. Severe decrease in peripheral blood dendritic cells in hairy cell leukaemia. Br J Haematol 2002; 116: 595-597.
14. Mami NB, Mohty M, Chambost H, Gaugler B, Olive D. Blood dendritic cells in patients with acute lymphoblastic leukaemia. Br J Haematol 2004; 126: 77-80.
15. Vakkila J, Thomson AW, Vettenranta K, Sariola H, Saarinen-Pihkala UM. Dendritic cell subsets in childhood and in children with cancer: relation to age and disease prognosis. Clin Exp Immunol 2004; 135: 455-461.
16. Teig N, Moses D, Gieseler S, Schauer U. Age-related changes in human blood dendritic cell subpopulations. Scand J Immunol 2002; 55: 453-457.
17. Dzionek A, Fuchs A, Schmidt P, Cremer S, Zysk M, Miltenyi S et al. BDCA-2, BDCA-3, and BDCA-4: Three markers for distinct subsets of dendritic cells in human peripheral blood. J Immunol 2000; 165: 6037-6046.
18. Gabrilovich D. Mechanisms and functional significance of tumour-induced dendritic-cell defects. Nat Rev Immunol 2004; 4: 941-952.
19. Troy AJ, Summers KL, Davidson PJ, Atkinson CH, Hart DN. Minimal recruitment and activation of dendritic cells within renal cell carcinoma. Clin Cancer Res 1998; 4: 585-593.
20. Nestle FO, Burg G, Fah J, Wrone-Smith T, Nickoloff BJ. Human sunlight-induced basal-cell-carcinoma-associated dendritic cells are deficient in T cell co-stimulatory molecules and are impaired as antigen-presenting cells. Am J Pathol 1997; 150: 641-651.
21. Gabrilovich DI, Corak J, Ciernik IF, Kavanaugh D, Carbone DP. Decreased antigen presentation by dendritic cells in patients with breast cancer. Clin Cancer Res 1997; 3: 483-490.
22. Cloppenborg T, Stanulla M, Zimmermann M, Schrappe M, Welte K, Klein C. Immunosurveillance of childhood ALL: Polymorphic interferon-gamma alleles are associated with age at diagnosis and clinical risk groups. Leukemia 2005; 19: 44-48.
23. Lauten M, Matthias T, Stanulla M, Beger C, Welte K, Schrappe M. Association of initial response to prednisone treatment in childhood acute lymphoblastic leukaemia and polymorphisms within the tumour necrosis factor and the interleukin-10 genes. Leukemia 2002; 16: 1437-1442.